483
Alexion Pharmaceuticals, Inc.Alexion Pharmaceuticals, Inc. – FDA 483, Mar 7, 2025
Record Details
An FDA inspection of Alexion Pharmaceuticals, Inc. in Boston, MA, revealed a significant issue regarding the firm's compliance with its approved REMS Implementation System for the drug Voydeya. The company failed to adhere to its audit plan and schedule for certified pharmacies and did not maintain adequate records to ensure restricted distribution of the medication. This indicates a moderate severity issue related to drug distribution controls and oversight.
- Person
View Company Profile
ID · a419172e-26c2-47cb-9836-f572daa92416
Other documents for Alexion Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.